Immunomodulating activities of soluble synthetic polymer-bound drugs
Language English Country Netherlands Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
12204597
DOI
10.1016/s0169-409x(02)00043-1
PII: S0169409X02000431
Knihovny.cz E-resources
- MeSH
- Adjuvants, Immunologic administration & dosage chemistry pharmacology MeSH
- Killer Cells, Natural drug effects MeSH
- Doxorubicin administration & dosage pharmacology MeSH
- Humans MeSH
- Fas Ligand Protein MeSH
- Macrophages drug effects MeSH
- Membrane Glycoproteins immunology MeSH
- Methacrylates MeSH
- Neoplasms drug therapy immunology MeSH
- Drug Carriers MeSH
- Polymers * pharmacology MeSH
- Antineoplastic Agents administration & dosage pharmacology MeSH
- Solubility MeSH
- Vaccines administration & dosage MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Adjuvants, Immunologic MeSH
- Doxorubicin MeSH
- FASLG protein, human MeSH Browser
- hydroxypropyl methacrylate MeSH Browser
- Fas Ligand Protein MeSH
- Membrane Glycoproteins MeSH
- Methacrylates MeSH
- Drug Carriers MeSH
- Polymers * MeSH
- Antineoplastic Agents MeSH
- Vaccines MeSH
The introduction of a synthetic material into the body always affects different body systems, including the defense system. Synthetic polymers are usually thymus-independent antigens with only a limited ability to elicit antibody formation or to induce a cellular immune response against them. However, there are many other ways that they influence or can be used to influence the immune system of the host. Low-immunogenic water-soluble synthetic polymers sometimes exhibit significant immunomodulating activity, mainly concerning the activation/suppression of NK cells, LAK cells and macrophages. Some of them, such as poly(ethylene glycol) and poly[N-(2-hydroxypropyl)methacrylamide], can be used as effective protein carriers, as they are able to reduce the immunogenicity of conjugated proteins and/or to reduce non-specific uptake of liposome/nanoparticle-entrapped drugs and other therapeutic agents. Recently, the development of vaccine delivery systems prepared from biodegradable and biocompatible water-soluble synthetic polymers, microspheres, liposomes and/or nanoparticles has received considerable attention, as they can be tailored to meet the specific physical, chemical, and immunogenic requirements of a particular antigen and some of them can also act as adjuvants.
References provided by Crossref.org